GENE ONLINE|News &
After Amyloid, Drugmakers Push Into the Next Generation of Alzheimer’s Therapies
Tau-targeting therapies, antisense oligonucleotides, blood-based diagnostics, and AI-assisted discovery are converging to challenge assumptions that have governed neurological research for thirty years.
For three decades, the dominant framework in Alzheimer’s research rested on a single premise: that amyloid-beta plaques were the primary driver of the disease, and …
After Amyloid, Drugmakers Push Into the Next Generation of Alzheimer’s Therapies Read More »
It's free! Log in now to read
LATEST
University of Houston Researchers Use AI to Analyze Police Crash Narratives for Pavement Safety Improvements
2026-07-16
Yale Study Finds Federal Regulations for Wild American Ginseng May Not Reflect Plant Health
2026-07-16
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
